Being aware if youve previously had conditions such as pancreatitis, gallbladder disease or liver enzyme changes is important, as these are uncommon yet significant risks
Their benefits especially for weight management tend to reverse when treatment is stopped
M.CarrilloM
Both hepatic and non-hepatic mechanisms contribute to the development of hepatic steatosis
References Pfizer Completes Acquisition of Metsera, 13 November 2025, Pfizer, Pfizer completes $10bn acquisition of Metsera to kickstart its GLP-1 goals, Manufacturing chemist, 14 November 2025, Pfizer completes up to $10 billion acquisition of Metsera, 13 November 2025, Reuters, Pfizer closes $10 billion Metsera deal, 14 November 2025, Stat10,
Clinical research has demonstrated PT-141s efficacy in supporting sexual function, particularly in cases where traditional treatments have been ineffective